Research Article
Volume 3 Issue 5 - 2020
A Unique Experience with Mental and Developmental Retardation: Innovative Medical Therapies for Idiopathic Mental Retardation
Aamir Jalal Al-Mosawi1,2*
1Advisor in Pediatrics and Pediatric Psychiatry, Children Teaching Hospital of Baghdad Medical City, Baghdad, Iraq
2Head, Iraq Headquarter of Copernicus Scientists International Panel, Baghdad, Iraq
*Corresponding Author: Aamir Jalal Al-Mosawi, Advisor in Pediatrics and Pediatric Psychiatry, Children Teaching Hospital of Baghdad Medical City and Head, Iraq Headquarter of Copernicus Scientists International Panel, Baghdad, Iraq.
Received: March 19, 2020; Published: April 13, 2020




Abstract

Background: Until, 2016, there have been no specialized consultation clinic nor medical treatment services for children with mental and developmental retardation and other childhood psychiatric disorders in Iraq. However, early during the year 2017, a pediatric psychiatry (neuropsychiatry) consultation clinic was established at the Children Teaching Hospital of Baghdad Medical City with aim of providing evidence-based consultations and evidence-based medical therapies and also conducting a pediatric psychiatry training courses. Many of the scientific practices and disease patterns at the pediatric neuropsychiatry clinic were documented earlier through scientific publishing. The aim of this paper is to describe new our experiences with mental and developmental retardation with emphasis on recently used innovative medical therapies for idiopathic mental retardation.

Patients and Methods: During nine months period (from March to December, 2019), eighty patients (55 males and 25 female) with mental and developments retardation were studied at the Children Teaching Hospital of Baghdad Medical City. Their ages ranged from 4 months to sixteen years.

Results: Idiopathic mental retardation accounted for 51%, Down syndrome 8.75, Cornelia De Lang syndrome accounted for 6.25%. Most of the patients especially patients with idiopathic mental retardation were treated based on our previously published experiences with individualized courses of medical therapies with aim of improving the quality of their life by improving adaptive skills including bowel control and spoon feeding, improving cognition and understanding, improving their fine motor skills and with the ultimate aim of making them more educable. However, it was not possible to record the treatment courses of all patients, but it was possible to demonstrate a beneficial effect of treatments in four patients.

Conclusion: In this study, the most common causes of mental and developmental retardation were idiopathic mental retardation accounting for 51%, Down syndrome accounting for (8.75%) and Cornelia De Lang syndrome accounting for 6.25%. The use of innovative multifactorial therapies was helpful in the management of idiopathic mental retardation.

Keywords: Mental Retardation; Iraq; Innovative Therapies

References

  1. Al-Mosawi AJ. “The use of cerebrolysin and citicoline in autism and Asperger syndrome”. Journal of Bio Innovation 1 (2019): 99-108.
  2. Al-Mosawi AJ. “New therapies for Rett syndrome”. Journal of Bio Innovation 3 (2019): 301-307.
  3. Al-Mosawi AJ. “Heller syndrome in two Iraqi children”. Clinical Research and Trials 5 (2019): 1-3.
  4. Al-Mosawi AJ. “Pervasive developmental disorders in Iraqi Children”. Journal of Psychiatry Research Reviews and Reports1 (2019): 1-8.
  5. Al-Mosawi AJ. “The etiology of mental retardation in Iraqi children”. Sun Krist Journal of Neonatology and Pediatrics1(2019): 1-9.
  6. Al-Mosawi AJ. “Asperger syndrome and regressive autism”.1st edition, Saarbrücken; LAP Lambert Academic Publishing (2018).
  7. Al-Mosawi AJ. “A new therapeutic approach for pervasive developmental disorders”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2018).
  8. Al-Mosawi AJ. “A novel therapeutic approach for idiopathic mental retardation”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2018).
  9. Al-Mosawi AJ. “The pattern of mental retardation in Iraqi children”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2019).
  10. Al-Mosawi AJ. “Childhood dementia: Heller syndrome”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2019).
  11. Al-Mosawi AJ. “The pattern of pervasive developmental disorders in Iraqi children”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2019).
  12. Al-Mosawi AJ. “Gilles de La Tourette syndrome”. 1st, Saarbrücken; LAP Lambert Academic Publishing (2018).
  13. Al-Mosawi AJ. “Pediatric psychiatry: An accredited training course”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2018).
  14. Al-Mosawi AJ. “Our Experience with Childhood Pervasive Developmental Disorders (Autism and Asperger Syndrome): Cure is Possible”. EC Clinical and Medical Case Reports4 (2020): 01-08.
  15. Al-Mosawi AJ. “Cornelia De Lange Syndrome in Iraq”. Clinical medical reviews and reports: Open access2 (2020): 1-4.
  16. Al-Mosawi AJ. “Noonan syndrome with CT-scan evidence of brain atrophy and ventriculomegaly”. Journal of Clinical Research and Reports1 (2019): 003.
  17. Al-Mosawi AJ. “The second case of Noonan syndrome in Iraq: The association with unique multiple cardiac defects”. Cardiology Research and Reports1 (2020): 1-3.
  18. Al-Mosawi AJ. “The thirty fourth and thirty fifth cases of Goldberg Shprintzen Syndrome”. Journal of Clinical Research and Reports 1 (2020): 1-4.
  19. Al-Mosawi AJ. “The use of piracetam and cerebrolysin in the treatment of agenesis of corpus callosum with colpocephaly”. EC Clinical and Medical Case Reports1 (2020): 01-05.
  20. Al-Mosawi AJ. “Congenital myotonic muscular dystrophy: The diagnostic role of nerve conduction study and needle electromyography”. Canadian Journal of Biomedical Research and Technology4 (2020): 1-3.
  21. Al-Mosawi AJ. “The Case Number 130 of Townes Brocks syndrome”. Clinics in Medicine3 (2019).
  22. Al-Mosawi AJ. “The third case of the extended Michelin tire baby syndrome associated with undescended testis, mental retardation and hearing impairment”. The New American Journal of Medicine2 (2019): 1-3.
  23. Al-Mosawi AJ. “Mowat Wilson syndrome associated with pseudo rocker bottom feet deformity”. Journal Clinical Research and Reports 3 (2020): 1-6.
  24. Al-Mosawi AJ. “The 58th Case of Toriello-Carey Syndrome: The Association with Colpocephaly on Brain Magnetic Resonance Imaging and Computerized Tomography Scan”. Journal of Clinical Research in Radiology2 (2019): 1-4.
  25. Al-Mosawi AJ. “Dandy walker syndrome with unusual presentation and unusual radiologic sign on Ct-Scan”. International Journal of Radiology Sciences1 (2019): 15-17.
  26. Al-Mosawi AJ. “Reverse slanting of split eyebrows and palpebral fissures: A new congenital syndrome”. Journal of Ophthalmology and Optometry1 (2019): 004.
  27. Al-Mosawi AJ. “Reverse slanting of split eyebrows and palpebral fissures: A new congenital syndrome”. Global Journal of Medical Research: F Diseases0 (2020): 1-5.
  28. Al-Mosawi AJ. “Facial dysmorphism, mental retardation, triphalangeal toes and unilateral renal agenesis: A new syndrome”. International Invention of Scientific Journal9 (2019): 683-686.
  29. Al-Mosawi AJ. “Mental-growth retardation, microphthalmia, microcornea, iris and uvea colobomata, transient ocular hypopigmentation, and contralateral optic disc colobomata, and dilated third ventricle: A new syndrome”. Journal of Clinical Review and Case Reports 9 (2019): 1-3.
  30. Al-Mosawi AJ. “Congenital Partial Hemihypertrophy, Low Set Ears, Hypertelorism, and Epicanthi Folds: A Novel Syndromic Association”. Clinical Research Notes1 (2020).
  31. Al-Mosawi AJ. “Psychomotor retardation, low set ears, retrognathia, facial dysmorphism and schizencephaly: A new dysmorphic syndrome”. Journal of Clinical Research and Reports 3 (2020): 1-2.
  32. Al-Mosawi AJ. “Clinical uses of Cerebrolysin in Pediatric Neuropsychiatry”. Science World Journal of Pharmaceutical Sciences1 (2020): 1-4.
  33. Al-Mosawi AJ. “A new therapeutic approach for the treatment of brain atrophy”. 1st, Saarbrücken; LAP Lambert Academic Publishing (2017).
  34. Al-Mosawi AJ. “New therapies for the treatment of spastic cerebral palsy”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2019).
  35. Al-Mosawi AJ. “The Pattern of Cerebral Palsy in Iraqi Children”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing (2019).
  36. Al-Mosawi AJ. “New Therapies for the treatment of spastic cerebral palsy”. Medical Journal of Clinical trials and Case Studies 2 (2019): 000209.
  37. Al-Mosawi AJ. “The novel use of cerebrolysin and citicoline in the treatment of kernicterus”. Online Journal of Neurology and Brain Disorders1 (2019): 208-212.
  38. Al-Mosawi AJ. “The use of cerebrolysin in pediatric Wohlfart Kugelberg Welander syndrome”. MOJ Clinical and Medical Case Reports1 (2020): 20-23.
  39. Al-Mosawi AJ. “The use of Cerebrolysin in Pediatric Charcot Marie Tooth Disease”. Journal of Neurological Research and Therapy2 (2020): 17-21.
  40. Al-Mosawi AJ. “New medical therapies for the treatment of myelomeningocele”. Surgical Medicine Open Access Journal4 (2019): 1-4.
  41. Al-Mosawi AJ. “Citicoline research progress”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing: (2019).
  42. Al-Mosawi AJ. “The Use of Citicoline in Pediatric Neurology and Pediatric Psychiatry”. Austin Pediatrics1 (2019): 1071-1072.
Citation: Aamir Jalal Al-Mosawi. ““A Unique Experience with Mental and Developmental Retardation: Innovative Medical Therapies for Idiopathic Mental Retardation”. EC Clinical and Medical Case Reports 3.5 (2020): 42-54.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for October Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the November issue of respective journals. Submissions are accepted on/before October 07, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk